+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Anti-CTLA4 Antibody Clinical Trials in Melanoma

, : Anti-CTLA4 Antibody Clinical Trials in Melanoma. Update on Cancer Therapeutics 2(3): 133-139

The cytotoxic T lymphocyte-associated protein 4 (CTLA4) is a main negative regulator of the immune system, which inhibits the costimulatory signaling for T cells. Preclinical studies demonstrated that antibodies against CTLA4 induced regression of some murine tumors. Two CTLA4 blocking monoclonal antibodies have entered clinical development and are currently in pivotal clinical trial testing. Ipilimumab (formerly MDX010) is an IgG1 and tremelimumab (formerly CP-675,206 and transiently ticilimumab), is an IgG2, both being fully human monoclonal antibodies. Across several early clinical trials, including dose escalation, single dose, multi-dose, and in combination with a variety of other immune stimulants like peptide vaccines or interleukin-2, objective tumor responses in patients with metastatic melanoma have been observed in the in the range of 5 to 20%. A key feature is that some of these responses are extremely long-lived responses, lasting years. The early clinical testing also demonstrated that these CTLA4 blocking antibodies can lead to significant toxicities, most with an inflammatory or immune mediated mechanism of action. These include colitis and skin rash as the most common toxicities, and a variety of autoimmune and inflammatory processes against multiple organs. Some of these toxicities require immune suppressive therapy and may lead to permanent damage in occasional patients. In conclusion, two monoclonal antibodies blocking CTLA4 have demonstrated ability to break tolerance to self-tissues and result in long lasting objective cancer regressions, and have moved onto late stages of clinical development.


PMID: 19543441

DOI: 10.1016/j.uct.2007.09.001

Other references

Boyer, S.A., 1999: Courses without classrooms. There is an alternative to classroom lecture that provides faster, more complete instruction and introduces the learner to clinical application of skills in a safe environment. This teaching style uses multiple media to present professional, publi...

Baluyot, S.Alec.C.; Hermosa, N.P., 2009: Intensity profiles and propagation of optical beams with bored helical phase. A modification of the helical phase profile obtained by eliminating the on-axis screw-dislocation is presented. Beams with this phase possess a variety of interesting properties different from optical vortex beams. Numerical simulations verify ana...

Tascon, M.; Gómez-Ríos, Gán.Augusto.; Reyes-Garcés, N.; Poole, J.; Boyacı, E.; Pawliszyn, J., 2017: High-Throughput Screening and Quantitation of Target Compounds in Biofluids by Coated Blade Spray-Mass Spectrometry. Most contemporary methods of screening and quantitating controlled substances and therapeutic drugs in biofluids typically require laborious, time-consuming, and expensive analytical workflows. In recent years, our group has worked toward developi...

Qarawi, M.A.; Carrington, S.; Blagbrough, I.S.; Moss, S.H.; Pouton, C.W., 1995: Inhibition of growth of B16 mouse melanoma cells by novel spermine analogues. Pharmaceutical Research (New York) 12(9 SUPPL ): S128

Steensma, D.P.; Kyle, R.A.; Shampo, M.A., 2016: J. Robin Warren: Helicobacter Pylori and Peptic Ulcer. Mayo Clinic Proceedings 91(9): E129-E130

Singhal, A.; Doherty, J.F.; Raynes, J.G.; Mcadam, K.P.W.J.; Thomas, P.W.; Serjeant, B.E.; Serjeant, G.R., 1993: Is there an acute-phase response in steady-state sickle cell disease?. Metabolic and serum changes during steady-state homozygous sickle cell (SS) disease are consistent with an acute-phase response and raise the possibility that inflammation occurs in SS disease even duuring the steady state. To test this hypothesis...

Birenheide, R., 1990: Zur palokologischen Bedeutung des Stereoplasmas in cystimorphen Deckelkorallen. Natur und Museum (Frankfurt am Main): 1205: 129-138

Van Obberghen-Schilling, E.; Thompson, N.L.; Flanders, K.C.; Sporn, M.B.; Lambert, P.F.; Baker, C.C., 1990: Transforming growth factor-beta expression in fibropapillomas induced by bovine papillomavirus type 1, in normal bovine skin, and in BPV-1-transformed cells. There is substantial evidence to suggest that transforming growth factor-beta (TGF-beta) plays an important role in wound healing and tissue repair as well as in carcinogenesis. It has also been observed that naturally occurring bovine papillomavi...

Czernielewski, A.; Hordyńska, S.; Korczyński, E.; Legatowa, B.; Musialowicz, D., 1974: Physico-chemical and dermatologic evaluation of a shampoo of Polish production. Roczniki Panstwowego Zakladu Higieny 25(2): 191-201

Barreto, R.E.ydio; Luchiari, A.C.rolina; Marcondes, A.L.cia, 2003: Ventilatory frequency indicates visual recognition of an allopatric predator in naive Nile tilapia. Perceiving a possible predator may promote physiological changes to support prey 'fight or flight'. In this case, an increase in ventilatory frequency (VF) may be expected, because this is a way to improve oxygen uptake for escape tasks....